phase readout
saveNCT07258641: Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: University Medical Center Groningen. Phase: PHASE1. Conditions: Ulcerative Colitis (UC), Crohn Disease (CD)
view source ↗
comments(0)
5-min edit window · permanent after that